Investment Banking Update: Notable March Transactions and Cautious Optimism Ahead BlogInvestment Banking TeamApril 3, 2023Investment Banking, Capital, Markets, Investing, Biotech, Medtech
The Transactional Landscape Of ADCs: A Payday for Payloads BlogBack Bay Life Science AdvisorsMarch 2, 2023Capital, Biotech, M&A, Oncology, Transactions, Deal Landscape, Small Molecule Therapeutics
Healthcare Companies Venture Back into Public Markets BlogInvestment Banking TeamFebruary 27, 2023Investment Banking, Capital, Markets, Investing, Biotech, Medtech
Proving the Promise of Gene Replacement and Editing in Treatment of Inherited Blood Diseases BlogBack Bay Life Science AdvisorsFebruary 24, 2023Capital, Biotech, Cell therapy, Cell and Gene
Canadian Venture Capital-Funded Biotech Companies to Watch in 2023 ArticleBack Bay Life Science AdvisorsFebruary 1, 2023VC, Funding, Canadian, Biotech, US Biotech
2023: A Year for NASH Revival? BlogBack Bay Life Science AdvisorsJanuary 23, 2023NASH, Liver, Biotech, Life Sciences Development, Partnering, Investment
Prepare for What the Markets Could Bring BlogInvestment Banking TeamJanuary 18, 2023Investment Banking, Capital, Markets, Investing, Biotech, Medtech
New Podcast with Back Bay and Nasdaq: Preparing Biopharma and Medtech Companies for Public Listing PodcastBack Bay Life Science AdvisorsSeptember 20, 2022Mergers, Podcast, Investment Banking, Public Listing, Biotech
Versantis to be acquired by GENFIT Press Release, Client NewsBack Bay Life Science AdvisorsSeptember 19, 2022Transactions, Diligence, Biotech, M&A
Trends, Opportunities, and Outlooks for Investment in the US Biotech Market WebinarBack Bay Life Science AdvisorsJanuary 4, 2022Biotech, Biotech Investment, Canada
New Drug Pricing and Market Access [Podcast] PodcastBack Bay Life Science AdvisorsJuly 6, 2021Biotech, Market Access, Drug Pricing, FDA
Investment Banking Spotlight: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals Back Bay Deal TeamInvestment Banking TeamFebruary 23, 2021Biotech, M&A, Drug Development, Cannabidiol, Blockbuster, Life Sciences
2020 IPO Class Performance Investment Banking Update, BlogBack Bay Life Science AdvisorsSeptember 23, 2020Biotech Financing, IPOs, Biotech, Investment Banking
STAT NEWS: Why Medtech is a Different Beast Than Biotech in the Life Sciences Pack Insights, Jonathan GertlerJonathan Gertler, MDFebruary 13, 2020Biotech, Medtech, diagnostics
